{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:26:28Z","timestamp":1780525588857,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","gastro.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.gtc.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T12:31:38Z","timestamp":1464870698000},"page":"333-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Metabolic Bone Disease in Primary Biliary Cirrhosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Lisa M.","family":"Glass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Li-Chun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.gtc.2016.02.009_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.gtc.2016.02.009_bib2","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.gastro.2003.08.022","article-title":"Pediatric-onset primary biliary cirrhosis","volume":"125","author":"Dahlan","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2016.02.009_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"10003","key":"10.1016\/j.gtc.2016.02.009_bib4","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2016.02.009_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0034-1383725","article-title":"Genetics and epigenetics of primary biliary cirrhosis","volume":"34","author":"Bianchi","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.gtc.2016.02.009_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.175.1.575","article-title":"X\u00a0chromosome monosomy: a common mechanism for autoimmune diseases","volume":"175","author":"Invernizzi","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.gtc.2016.02.009_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis","volume":"363","author":"Invernizzi","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gtc.2016.02.009_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhep.2001.26514","article-title":"Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens","volume":"34","author":"Miyakawa","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gtc.2016.02.009_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Par\u00e9s","year":"2006","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/j.gtc.2016.02.009_bib10","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"330","author":"Poupon","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.gtc.2016.02.009_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.gtc.2016.02.009_bib12","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2016.02.009_bib13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.gtc.2016.02.009_bib14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","article-title":"AGA technical review on osteoporosis in hepatic disorders","volume":"125","author":"Leslie","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2016.02.009_bib15","series-title":"Bone health and osteoporosis: a report of the surgeon general","author":"US Department of Health and Human Services","year":"2004"},{"key":"10.1016\/j.gtc.2016.02.009_bib16","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"329","article-title":"Vitamin D-related disorders","author":"Lips","year":"2008"},{"key":"10.1016\/j.gtc.2016.02.009_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","article-title":"Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment","volume":"12","author":"Pares","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2016.02.009_bib18","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","article-title":"Bone mineral density before and after OLT: long-term follow-up and predictive factors","volume":"12","author":"Guichelaar","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2016.02.009_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","volume":"35","author":"Menon","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2016.02.009_bib20","first-page":"1356","article-title":"Factors influencing the development of metabolic bone disease in primary biliary cirrhosis","volume":"85","author":"Guanabens","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.02.009_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0168-8278(00)80541-3","article-title":"Pretransplant bone histomorphometric status of patients with end-stage cholestatic liver disease","volume":"32","author":"Guichelaar","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2016.02.009_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Guanabens","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2016.02.009_bib23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2006.09.012","article-title":"Fracture risk in people with primary biliary cirrhosis: a population-based cohort study","volume":"131","author":"Solaymani\u2013Dodaran","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2016.02.009_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/2230-8210.83401","article-title":"Role of RANKL\u2013RANK\/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications","volume":"15","author":"Kohli","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.gtc.2016.02.009_bib25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","article-title":"The pathophysiology and treatment of osteoporosis","volume":"37","author":"Drake","year":"2015","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.gtc.2016.02.009_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/jhep.2002.36357","article-title":"Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry","volume":"36","author":"Guichelaar","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2016.02.009_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0016-5085(82)80292-8","article-title":"Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D","volume":"83","author":"Herlong","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2016.02.009_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0016-5085(82)80291-6","article-title":"Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment","volume":"83","author":"Matloff","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2016.02.009_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2362.2009.02230.x","article-title":"Lithocholic acid downregulates vitamin D effects in human osteoblasts","volume":"40","author":"Ruiz-Gaspa","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.gtc.2016.02.009_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1760339","article-title":"Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture","volume":"176","author":"Koshihara","year":"2003","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.gtc.2016.02.009_bib31","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archinte.166.12.1256","article-title":"Vitamin K and the prevention of fractures","volume":"166","author":"Cockayne","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.gtc.2016.02.009_bib32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2006.06.007","article-title":"Treatment of bone disorders in liver disease","volume":"45","author":"Pares","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2016.02.009_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jbmr.2608","article-title":"Long-term exercise and Bone Mineral density changes in postmenopausal women- are there periods of reduced effectiveness?","volume":"31","author":"Kemmler","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.gtc.2016.02.009_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1440-1746.1999.01913.x","article-title":"Calcitriol for bone disease in patients with cirrhosis of the liver","volume":"14","author":"Shiomi","year":"1999","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2016.02.009_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s005350050250","article-title":"Calcitriol for bone loss in patients with primary biliary cirrhosis","volume":"34","author":"Shiomi","year":"1999","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.gtc.2016.02.009_bib36","unstructured":"NOF\u2019s Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis. Available at: http:\/\/nof.org\/files\/nof\/public\/content\/file\/344\/upload\/159.pdf. Accessed October 25, 2015."},{"key":"10.1016\/j.gtc.2016.02.009_bib37","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1053\/j.gastro.2010.02.016","article-title":"Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis","volume":"138","author":"Guanabens","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2016.02.009_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cld.2005.07.003","article-title":"Evaluation and management of osteoporosis in liver disease","volume":"9","author":"Hay","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2016.02.009_bib39","unstructured":"Agency for Healthcare Research and Quality. Treatment to prevent osteoporotic fractures: An update. Available at: http:\/\/www.effectivehealthcare.ahrq.gov\/index.cfm. Accessed October 25, 2015."},{"key":"10.1016\/j.gtc.2016.02.009_bib40","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis","volume":"98","author":"Guanabens","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.02.009_bib41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","article-title":"Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial","volume":"42","author":"Zein","year":"2005","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.gtc.2016.02.009_bib42","article-title":"Bisphosphonates for osteoporosis in primary biliary cirrhosis","author":"Rudic","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gtc.2016.02.009_bib43","first-page":"2070","article-title":"A\u00a0randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis","volume":"58","author":"Guanabens","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2016.02.009_bib44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1572-0241.2003.07341.x","article-title":"Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis","volume":"98","author":"Menon","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.02.009_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2036.2004.01890.x","article-title":"Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial","volume":"19","author":"Pereira","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2016.02.009_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2005.01026.x","article-title":"Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study","volume":"25","author":"Levy","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.gtc.2016.02.009_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0168-8278(91)90941-4","article-title":"Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment","volume":"12","author":"Floreani","year":"1991","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2016.02.009_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004836-199706000-00012","article-title":"A\u00a03-year pilot study with 1,25-diydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis","volume":"24","author":"Floreani","year":"1997","journal-title":"J\u00a0Clin Gastroenterol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855316300097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855316300097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T14:11:48Z","timestamp":1600697508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855316300097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0889855316300097"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2016.02.009","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Bone Disease in Primary Biliary Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}